SMTL ID : 2a4r.1

HCV NS3 Protease Domain with a Ketoamide Inhibitor Covalently bound.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

hetero-2-2-mer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.108, T.109, C.110, C.156 4 PLIP interactions: 3 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:C.108, A:C.110, A:C.156, H2O.1 ZN.3: 4 residues within 4Å: Chain C: C.108, T.109, C.110, C.156 4 PLIP interactions: 3 interactions with chain C, 1 Ligand-Water interactions Metal complexes: C:C.108, C:C.110, C:C.156, H2O.4

1 x BNH: [(N-{3-[(N-{CYCLOHEXYL[(ISOBUTOXYCARBONYL)AMINO]ACETYL}-3-CYCLOPROPYLALANYL)AMINO]-4-CYCLOPROPYL-2-OXOBUTANOYL}GLYCYL)AMINO](PHENYL)ACETIC ACID(Covalent)

BNH.2: 18 residues within 4Å: Chain A: Q.52, T.53, F.54, H.68, R.134, I.143, L.146, K.147, G.148, S.149, S.150, F.165, R.166, A.167, A.168, V.169, C.170, D.179 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:T.53, A:I.143, A:I.143, A:K.147, A:F.165, A:A.167, A:A.168, A:V.169, A:D.179 Hydrogen bonds: A:Q.52, A:T.53, A:T.53, A:T.53, A:G.148, A:S.150, A:S.150, A:R.166, A:A.168, A:A.168

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bogen, S. et al., Hepatitis C Virus NS3-4A serine protease inhibitors: Use of a P2-P1 cyclopropyl alanine combination for improved potency. Bioorg.Med.Chem.Lett. (2005)

Release Date

2006-07-04

Peptides

NS3 protease/helicase: AC
Ns4a peptide: BD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

C
C

B
B

D
D

NS3 protease/helicase

Ns4a peptide

Related Entries With Identical Sequence